This content is viewable by members only. Visit MY ACCOUNT on the top menu to log in or to register for a 30 day free trial or purchase a subscription for UV Reporter 1 Year Single Membership or UV Reporter 1 Year Group Membership - $189 for first member and $25 for each additional member.
Pilot Study of Application of Combined Transbronchial and Intravenous Ultraviolet C (UVC) and Laser Beam Application for the Treatment of Critical COVID-19 Infection
See t.ly/hUNp –Injecting sunlight, perhaps, isn’t such a far-fetched idea. Objective and background: Light-based antimicrobials, mainly ultraviolet C (UVC) and laser light irradiation, have a potential to inactivate severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The aim of our study was to evaluate the effect of transbronchial and intravenous application of UVC and laser light irradiation on treatment of patients with severe COVID-19. Methods: The clinical outcome of six patients (age 42-69 years) with severe COVID-19 infection who were directly applied UVC (254 nm) transbronchially, and UVC plus green (630 nm) and red laser (535 nm) lights to the…
Published in Informational
More from InformationalMore posts in Informational »
- Congressman Sanford D. Bishop Jr. Presents Federally Funded Check to Leesburg, GA to Include UV Wastewater Treatment
- Westmoreland, PA Approves $31 M in Water Treatment Plant Upgrades Including Ultraviolet Disinfection System
- Bioaerosol Chamber Disinfected with Ultraviolet Light Between Studies
- Morro’s Bay, CA Has $160M Water Treatment Online Ahead of Schedule and Includes UV Advanced Oxidation
- PURO UV, Ushio and Johnson Controls Join Forces to Further the Scientific Research of Far UV-C and Validate its Benefits to IAQ